12 employees
Speratum is a biotechnology company dedicated to research and development (R&D) of targeted molecular therapies for cancer treatment.
2014
$2M
from 2 investors over 2 rounds
Speratum raised $2M on February 1, 2018
Investors: Carao Ventures
Speratum raised $800K on March 24, 2014